Abstract
The drug, acamprosate, available now only in Europe, is showing promise as a new drug for treatment of alcoholism. Acamprosate, a calcium acetylhomotaurinate derivative, marketed as Campral throughout Europe, has been shown to be effective in relapse prevention with alcoholics. Recent studies support that acamprosate was used successfully in completed clinical trials with detoxified alcoholics in treatment centers throughout Europe.1-3
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
